These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24047696)

  • 1. Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).
    Garbers C; Kuck F; Aparicio-Siegmund S; Konzak K; Kessenbrock M; Sommerfeld A; Häussinger D; Lang PA; Brenner D; Mak TW; Rose-John S; Essmann F; Schulze-Osthoff K; Piekorz RP; Scheller J
    Cell Cycle; 2013 Nov; 12(21):3421-32. PubMed ID: 24047696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
    Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
    J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
    Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.
    Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B
    J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling.
    Arnold P; Boll I; Rothaug M; Schumacher N; Schmidt F; Wichert R; Schneppenheim J; Lokau J; Pickhinke U; Koudelka T; Tholey A; Rabe B; Scheller J; Lucius R; Garbers C; Rose-John S; Becker-Pauly C
    Sci Rep; 2017 Mar; 7():44053. PubMed ID: 28276471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells.
    Briso EM; Dienz O; Rincon M
    J Immunol; 2008 Jun; 180(11):7102-6. PubMed ID: 18490707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling.
    Flynn CM; Garbers Y; Lokau J; Wesch D; Schulte DM; Laudes M; Lieb W; Aparicio-Siegmund S; Garbers C
    Sci Rep; 2019 May; 9(1):7306. PubMed ID: 31086276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
    Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
    Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding.
    Garbers C; Jänner N; Chalaris A; Moss ML; Floss DM; Meyer D; Koch-Nolte F; Rose-John S; Scheller J
    J Biol Chem; 2011 Apr; 286(17):14804-11. PubMed ID: 21454673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells.
    Grabowska MM; Sandhu B; Day ML
    Cell Signal; 2012 Feb; 24(2):532-538. PubMed ID: 22024284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells.
    Ratchford AM; Baker OJ; Camden JM; Rikka S; Petris MJ; Seye CI; Erb L; Weisman GA
    J Biol Chem; 2010 Mar; 285(10):7545-55. PubMed ID: 20064929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
    Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
    J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation.
    Riethmueller S; Somasundaram P; Ehlers JC; Hung CW; Flynn CM; Lokau J; Agthe M; Düsterhöft S; Zhu Y; Grötzinger J; Lorenzen I; Koudelka T; Yamamoto K; Pickhinke U; Wichert R; Becker-Pauly C; Rädisch M; Albrecht A; Hessefort M; Stahnke D; Unverzagt C; Rose-John S; Tholey A; Garbers C
    PLoS Biol; 2017 Jan; 15(1):e2000080. PubMed ID: 28060820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE).
    Matthews V; Schuster B; Schütze S; Bussmeyer I; Ludwig A; Hundhausen C; Sadowski T; Saftig P; Hartmann D; Kallen KJ; Rose-John S
    J Biol Chem; 2003 Oct; 278(40):38829-39. PubMed ID: 12832423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic Cleavage Governs Interleukin-11 Trans-signaling.
    Lokau J; Nitz R; Agthe M; Monhasery N; Aparicio-Siegmund S; Schumacher N; Wolf J; Möller-Hackbarth K; Waetzig GH; Grötzinger J; Müller-Newen G; Rose-John S; Scheller J; Garbers C
    Cell Rep; 2016 Feb; 14(7):1761-1773. PubMed ID: 26876177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface.
    Sugaya S; Sakimoto T; Shoji J; Sawa M
    Jpn J Ophthalmol; 2011 May; 55(3):277-282. PubMed ID: 21523377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.
    McLoughlin RM; Hurst SM; Nowell MA; Harris DA; Horiuchi S; Morgan LW; Wilkinson TS; Yamamoto N; Topley N; Jones SA
    J Immunol; 2004 May; 172(9):5676-83. PubMed ID: 15100312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
    Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
    J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells.
    Tanida S; Joh T; Itoh K; Kataoka H; Sasaki M; Ohara H; Nakazawa T; Nomura T; Kinugasa Y; Ohmoto H; Ishiguro H; Yoshino K; Higashiyama S; Itoh M
    Gastroenterology; 2004 Aug; 127(2):559-69. PubMed ID: 15300588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.